CVL006 Combination Therapy in Advanced Solid Tumors

NCT07157956 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

NOT_YET_RECRUITING

Status

318

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumor

Interventions

DRUG: CVL006 combined with pemetrexed and carboplatin
DRUG: CVL006 in combination with SKB264
DRUG: CVL006 in combination with DS-8201
DRUG: CVL006 in combination with Enfortumab Vedotin

Sponsor

Convalife (Shanghai) Co., Ltd.